This finding is contrary to previous observations that TDOs originating from adenocarcinoma comprises only cells expressing KrasG12D, but not those that retain KrasWT, thus highlighting the critical roles of Kras activation in the development of adenocarcinoma [25,26,]. The gene discussed is KRAS; the disease is adenocarcinoma.